Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
Vallerie V. McLaughlin(University of Michigan), Werner Seeger(Justus-Liebig-Universität Gießen), Victor F. Tapson(Cedars-Sinai Medical Center), Melvyn Rubenfire, Robert Voswinckel(Justus-Liebig-Universität Gießen), Richard N. Channick(University of California, Los Angeles), Horst Olschewski(Sigmund Freud Privatuniversität Wien), Lewis J. Rubin(University of California San Diego), Raymond L. Benza(Triangle), Ivan M. Robbins(Vanderbilt University Medical Center)
Cited by 558
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Predicting Survival in Pulmonary Arterial Hypertension
|Circulation|2010|1.5k
Risk stratification and medical therapy of pulmonary arterial hypertension
|European Respiratory Journal|2018|834
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777